<DOC>
	<DOCNO>NCT02374671</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness VisAbility Micro Insert System improvement near visual acuity presbyopic patient .</brief_summary>
	<brief_title>A Clinical Trial The VisAbility Micro Insert System Presbyopic Patients</brief_title>
	<detailed_description>The objective study evaluate safety effectiveness VisAbility Micro Insert System improvement near visual acuity presbyopic patient . This prospective clinical study enroll determine eligible total 360 subject range age 45 60 year age 14 clinical site . Subjects implanted VisAbility Micro Insert primary eye fellow eye sooner 14 day later . Subjects examine one day , one week 1 , 2 , 3 , 6 , 12 , 18 24 month post-operatively .</detailed_description>
	<mesh_term>Presbyopia</mesh_term>
	<criteria>Subjects must Best Corrected Distance Visual Acuity ( BCDVA ) 20/20 eye Subjects must Distance Corrected Near Visual Acuity ( DCNVA ) @ 40 cm 20/50 , 20/63 , 20/80 eye Subjects must Uncorrected Near Visual Acuity ( UCNVA ) @ 40 cm 20/50 , 20/63 , 20/80 eye Subject 's Preoperative Manifest Refraction Spherical Equivalent ( MRSE ) eye must 0.75 +0.50 diopter 1.00 diopter astigmatism . Cycloplegic refraction spherical equivalent ( CRSE ) difference MRSE le equal 0.50 diopter . Subjects must require minimum add +1.25 great read 20/20 near ( 40 cm ) . Subjects must alert , mentally competent , able understand comply requirement clinical study , personally motivate abide requirement restriction clinical study . Patients must available followup period . Subjects must able provide write informed consent Pupil baseline percent change scotopic photopic le 30 % absolute difference le 1.00 mm scotopic photopic pupil size measure NeurOptics Pupillometer Subjects ocular inflammation , chronic uveitis , recurrent anterior posterior segment inflammatory condition either eye ; subject ocular systemic disease ( ) pose significant risk ocular inflammation include limited , autoimmune disorder ( e.g . rheumatoid arthritis , ankylose spondylitis , Reiter 's syndrome , ulcerative colitis , Chron 's disease , psoriasis , sarcoidosis , Bechet 's disease ) , infection ( toxoplasmosis , catscratch fever , West Nile virus , syphilis , tuberculosis , herpes zoster , herpes simplex , adenovirus ) , ocular trauma gout . Subjects scleral thickness le 530 micron measure 3.5 40.00 mm posterior superior temporal quadrant limbus either eye . Subjects history prior intraocular procedure ( e.g . corneal transplant , filter procedure glaucoma , vitrectomy , retinal detachment repair , cataract surgery ) prior refractive procedure ( e.g . LASIK ( laser situ keratomileusis ) , surface excimer , incisional surgery ) either eye . Subjects history prior extraocular muscle surgery orbital surgery . Subjects chronic ocular disease include limited corneal pathology , primary secondary glaucoma , iritis , herpes simplex , uveitis , trachoma , ocular pemphigoid , Sjogrens disease , uveal melanoma , Thyroid Related Immune Orbitopathy clinical significant retinal pathology either eye . Subjects acute ocular disease completely treat resolve least three month conjunctivitis , blepharitis , chalazion , corneal abrasion keratitis either eye . Subjects chronic systemic disease may affect eye , include limited diabetes , ulcerative colitis , systemic lupus erythematosus , Chron 's disease , collagen vascular disease , rheumatoid arthritis , bleed diathesis , systemic manifestation HIV/AIDS . Any uncontrolled systemic disease ( e.g . hypertension , cancer , etc . ) could compromise patient 's participation . Use medication Coumadin , could make surgical procedure difficult . Subjects use Coumadin , aspirin , NSAID ( nonsteroidal anti inflammatory drug ) medication order doctor must able provide write approval treat doctor discontinue medication least 10 day prior surgery . Subjects chronic ocular surface disease , include limited subject prior diagnosis chronic dry eye syndrome base test limit , corneal conjunctival staining , Ocular surface Disease Index symptom score Schirmer tear test . Subjects allergic medication use protocol Subjects pregnant , lactating , childbearing age adn practice medically approve method birth control .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Near Vision</keyword>
	<keyword>Reading Vision</keyword>
	<keyword>Reading Glasses</keyword>
	<keyword>Reading</keyword>
	<keyword>Readers</keyword>
</DOC>